Vieser Jaime's Form 4 filing
Alaunos Therapeutics, Inc.TCRT · filed Dec 1, 2022
- Accession no.
- 0000899243-22-037274
- Filed
- Dec 1, 2022
- Trade date
- Nov 29, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $812.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vieser JaimeCIK 0001846045 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2022 | Common Stock | PPurchaseAcquired | +1,250,000 | $0.65F2 | +$812,500 | 1,250,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The shares were purchased in a registered underwritten offering on November 29, 2022.
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney